Akimichi Morita Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

2/2023	English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
3/2020	Japanese guidance for use of biologics for psoriasis (the 2019 version).
9/2013	Japanese guidance for use of biologics for psoriasis (the 2013 version).
11/2004	New strategy for efficient selection of dendritic cell-tumor hybrids and clonal heterogeneity of resulting hybrids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akimichi Morita Research Topics

Disease

64	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 10/2006
24	Neoplasms (Cancer) 04/2024 - 01/2002
12	Psoriatic Arthritis 05/2023 - 09/2016
9	Atopic Dermatitis (Atopic Eczema) 02/2024 - 12/2005
9	Melanoma (Melanoma, Malignant) 11/2023 - 08/2008
8	Infections 03/2024 - 09/2013
6	Vitiligo 05/2024 - 06/2010
6	Inflammation (Inflammations) 11/2023 - 06/2005
6	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 07/2023 - 01/2019
5	Mycosis Fungoides 01/2023 - 06/2013
5	Skin Diseases (Skin Disease) 02/2022 - 10/2011
5	Pyoderma Gangrenosum 01/2021 - 03/2005
4	Pruritus (Itching) 02/2024 - 06/2014
4	Hypersensitivity (Allergy) 10/2023 - 08/2008
4	Pain (Aches) 09/2023 - 02/2009
4	Ulcer 01/2021 - 03/2005
4	Systemic Scleroderma (Systemic Sclerosis) 07/2020 - 03/2003
3	Acne Vulgaris 03/2024 - 02/2007
3	Rheumatoid Arthritis 10/2023 - 10/2014
3	Hemangiosarcoma (Angiosarcoma) 07/2023 - 08/2020
3	Arthritis (Polyarthritis) 02/2023 - 10/2014
3	Merkel Cell Carcinoma 01/2022 - 08/2020
3	Neoplasm Metastasis (Metastasis) 09/2021 - 12/2012
3	Extramammary Paget Disease (Paget Disease, Extramammary) 07/2020 - 05/2018
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020 - 05/2013
3	Erythema 02/2009 - 12/2006
2	Drug-Related Side Effects and Adverse Reactions 10/2023 - 09/2013
2	Hypertriglyceridemia 07/2023 - 02/2022
2	Immune System Diseases (Immune Disorders) 01/2023 - 01/2006
2	Wounds and Injuries (Trauma) 01/2023 - 04/2009
2	Tertiary Lymphoid Structures 01/2023 - 01/2022
2	Lymphatic Metastasis 01/2023 - 07/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 09/2007
2	Insulin Resistance 01/2022 - 06/2011
2	Hidradenitis Suppurativa 01/2021 - 09/2019
2	Sacroiliitis 01/2021 - 11/2019

Drug/Important Bio-Agent (IBA)

13	Monoclonal AntibodiesIBA 10/2023 - 01/2012
12	Adalimumab (Humira)FDA Link 02/2023 - 09/2013
11	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
10	secukinumabIBA 11/2023 - 12/2014
9	deucravacitinibIBA 03/2024 - 10/2018
8	apremilastIBA 03/2024 - 01/2022
8	TYK2 Kinase (Tyrosine Kinase 2)IBA 03/2024 - 10/2018
8	Interleukin-17 (Interleukin 17)IBA 11/2023 - 04/2011
8	Infliximab (Remicade)FDA Link 10/2023 - 09/2013
8	Ficusin (Psoralen)IBA 02/2022 - 02/2008
8	Proteins (Proteins, Gene)FDA Link 05/2020 - 08/2008
7	spesolimabIBA 10/2023 - 01/2021
6	Bexarotene (LGD1069)FDA Link 07/2023 - 01/2019
6	InterleukinsIBA 05/2023 - 01/2017
6	CytokinesIBA 05/2023 - 12/2014
6	Ustekinumab (CNTO 1275)FDA Link 03/2023 - 09/2013
6	AntigensIBA 03/2023 - 01/2002
5	Therapeutic UsesIBA 09/2013 - 01/2005
4	dupilumabIBA 12/2023 - 09/2020
4	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2019
4	SteroidsIBA 10/2023 - 12/2011
4	Interleukin-22 (IL-22)IBA 05/2023 - 04/2011
4	Interleukin-12 (IL 12)IBA 05/2023 - 09/2013
4	Immunoglobulin A (IgA)IBA 03/2023 - 03/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2023 - 11/2004
4	AntibodiesIBA 02/2023 - 04/2018
4	C-Reactive ProteinIBA 10/2022 - 01/2017
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2020 - 04/2009
3	NivolumabIBA 04/2024 - 01/2016
3	Prostaglandins AIBA 12/2023 - 06/2021
3	B7-H1 AntigenIBA 03/2023 - 08/2020
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
3	SmokeIBA 01/2023 - 01/2003
3	Immunoglobulins (Immunoglobulin)IBA 06/2021 - 06/2005
3	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 12/2012
3	mogamulizumabIBA 01/2020 - 05/2013
3	CollagenIBA 02/2008 - 01/2003
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2024 - 09/2020
2	Biosimilar PharmaceuticalsIBA 10/2023 - 10/2022
2	CT-P13IBA 10/2023 - 10/2022
2	SuspensionsIBA 07/2023 - 06/2011
2	Interleukin-23 (Interleukin 23)IBA 05/2023 - 02/2023
2	Immunoglobulin M (IgM)IBA 04/2023 - 01/2019
2	bimekizumabIBA 03/2023 - 01/2023
2	risankizumabIBA 02/2023 - 10/2022
2	Phosphodiesterase 4 InhibitorsIBA 12/2022 - 01/2022
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2022 - 01/2022
2	ixekizumabIBA 02/2022 - 01/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2016
2	ChemokinesIBA 01/2022 - 09/2021
2	tildrakizumabIBA 06/2021 - 06/2021
2	LigandsIBA 09/2020 - 01/2016

Therapy/Procedure

40	Therapeutics 01/2024 - 03/2005
13	Phototherapy (Light Therapy) 07/2023 - 03/2003
6	PUVA Therapy 09/2021 - 02/2008
4	Immunotherapy 01/2023 - 01/2016
4	Drug Therapy (Chemotherapy) 04/2020 - 03/2009
3	Excimer Lasers 05/2024 - 06/2010
3	Photochemotherapy (Photodynamic Therapy) 02/2022 - 03/2011
2	Gas Lasers 05/2024 - 09/2021
2	Radiotherapy 07/2023 - 08/2020
2	Biological Therapy 10/2022 - 10/2017
2	Aftercare (After-Treatment) 09/2022 - 12/2020
2	Oral Administration 02/2022 - 09/2021